Inspire Advisors’s Immunogen Inc IMGN Stock Holding History

Inspire Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-117	Closed	-$1K	–	778
2020 Q4	$1K	Buy	+117	New	+$682	﹤0.01%	776

Other funds holding IMGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Inspire Advisors's IMGN Position: Q1 2021 in Review

Inspire Advisors sold out of Immunogen Inc (IMGN) in Q1 2021, closing a stake of 117 shares — an estimated $1K sold.

Inspire Advisors first reported a position in IMGN in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2021.

Inspire Advisors reported no remaining Immunogen Inc position as of Q1 2021 after selling out during the quarter.
Inspire Advisors sold 117 Immunogen Inc shares in Q1 2021, an estimated $1K.
Inspire Advisors first reported a position in Immunogen Inc in Q4 2020 and held it in 1 quarter.
Inspire Advisors's Immunogen Inc position peaked at $1K in Q4 2020.
217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.